Aegis Living Was Created To Place People First in Senior and Assisted Living C... (d. I thought 'Why do people think this ...)

Aegis Living Was Created To Place People First in Senior and Assisted Living Communities

Date:6/26/2009

d. "I thought, 'Why do people think this is acceptable?'"

Dwayne founded Aegis Living with a simple but revolutionary manifesto: Treat all people with the highest degree of respect, compassion, and care.

Aegis Living is always developing innovative ways to improve health, quality of life, well-being and sense of community for its residents. That attitude has made Aegis Living a national leader in retirement and assisted living.

Aegis Living has been honored with multiple awards over the years. It was honored as one of the "Best Companies to Work For" five years in a row by Washington CEO Magazine. CEO Dwayne Clark was named "Health Entrepreneur of the Year" by Ernst and Young, and recently received a Lifetime Achievement Award from Senior Services on behalf of all the work he has done to change the industry.

In the near future, Aegis will open new communities. And it will continue growth on the West Coast, both "physically" through its new communities and "mentally" with innovative programs and exceptional staff to care for residents 24/7.

Living 4 Life, a new way of living for seniors

Through its new and innovative wellness program, Living 4 Life, Aegis is bringing to light an exclusive way to enhance and maximize life, health, and well-being through services and amenities that parallel world-class living. Living 4 Life is a wellness program that combines elements of mind, body, spirit and community to help maintain a long, healthy and active life for seniors. The program includes affiliations with faculty from local universities and Technogym, bringing together the best minds in their fields to maximize the benefits for all residents.

Employee First

In order to provide the best care possible for their residents, Aegis recruits the most highly skilled caregivers and provides them with a thorough training program. In an industry that
'/>"/>

SOURCE Aegis Living
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3
Related medicine news :

1. Aegis of Bellevue, the Finest in Senior Living Communities
2. Aegis Living Completes Purchase of Real Estate in Aptos
3. Neovasc Receives CE Mark Approval for Peripatch(TM) Aegis Staple Line Reinforcement Product
4. Aegis Living Focuses On Taking Care of Their Own in 2009
5. Aegis to Present on Global Stages : Company to Discuss How Manufacturing Process IntelligenceSupports Tech Transfer and Product Lifecycle Management
6. AegisLiving Purchases Property in Bellevue for New Senior Living Community
7. Aegis Health Group Revealed Next Generation of Employer-Based Health-Improvement Strategies at Nashville Conference
8. Alabamas Baptist Health System and Aegis Health Group Partner to Address Local Employers Health-Management Concerns
9. AegisLiving Partners With Technogym USA to Enhance Wellness Throughout Its Communities
10. Kiplingers Long-Term Care Consumer Video Sponsored by John Hancock Life Insurance Company Wins National Aegis Award
11. Aegis Therapies and Rocky Mountain University of Health Professions Announce Scholarship Recipients

Post Your Comments:

(Date:12/3/2009)...sue of Deutsches rzteblatt International contain...xperience with the novel influenza A virus (H1N1/0...t of the pandemic. Ralf Winzer and his coauthors f...ely evaluated data from a large clinical cohort of...2009; 106[47]: 770-6). Their medical-scientific ar...

(Date:12/3/2009)... 450 Deaths a day is still too many - s...k. , Atlanta, GA, Geneva,...3, 2009 -- The Measles Initiative announced today ...2000 and 2008, from an estimated 733 000 in 2000 t...perts warn of a resurgence in measles deaths if va...

(Date:12/3/2009)... Nutra Pharma will be conducting a webi...squo;s over-the-counter and prescription treatment... Plantation, FL (Vocus) Decem... biotechnology company that is developing treatmen...le Sclerosis (MS), has announced today that it wil...

(Date:12/3/2009)...ANTA ROSA, Calif., Dec. 3 Osseon T...eerable and curvable bone cement delivery needle) ...l) systems for percutaneous vertebral augmentation...alth Canada for marketing and clinical use in Cana... corresponds to FDA approval in the United States,...

(Date:12/3/2009)...AScientists at Boston Biomedical Research Institut...ound that combining two chemicals, one of which is...stroy a variety of protein structures known as amy...brain disorders such as Alzheimer,s, Huntington,s,... in the current issue of Nature Chemical Biology ...

Breaking Medicine News(10 mins):Health News:Global Measles Deaths Drop By 78%, But Resurgence Likely 2 Health News:Global Measles Deaths Drop By 78%, But Resurgence Likely 3 Health News:Global Measles Deaths Drop By 78%, But Resurgence Likely 4 Health News:Nutra Pharma Announces Upcoming Webinar to Discuss the Company's Over-the-Counter (OTC) and Prescription Treatments for Chronic Pain 2 Health News:Nutra Pharma Announces Upcoming Webinar to Discuss the Company's Over-the-Counter (OTC) and Prescription Treatments for Chronic Pain 3 Health News:Osseon Therapeutics, Inc. Announces it has Received Canadian Medical Device Licenses From Health Canada 2 Health News:Green tea chemical combined with another may hold promise for treatment of brain disorders 2

[0] The swine flu pandemic [0] Global Measles Deaths Drop By 78%, But Resurgence Likely [0] Nutra Pharma Announces Upcoming Webinar to Discuss the Company's Over-the-Counter (OTC) and Prescription Treatments for Chronic Pain [0] Osseon Therapeutics, Inc. Announces it has Received Canadian Medical Device Licenses From Health Canada [0] Green tea chemical combined with another may hold promise for treatment of brain disorders

... Dr. Wayne Andersen to discuss weight management...uot; which is helping thousands maintain permanent...le-Dublin, Ohio (PRWEB) April 30, 2009 -- Dr. Wayn...three free seminars in the Westerville-Dublin area...

... G1G Travel Insurance and Student Funding Group ...l safely; Tuition Fee protection programs also add...se, CA (PRWEB) April 30, 2009 -- With a rise in in...udent Funding Group (StuFund) to offer newly creat...

...and, Ore.) A brief intervention program consisti...ne calls boosted by tenfold the number of women c...the findings of a Kaiser Permanente Center for Hea...intervention programs can be effective in increasi...

...illion in Total Revenues for the Quarter , , SAN ... Realty Trust, Inc. (NYSE: BMR ), a real estate ...to the Life Science Industry(R), today announced o...ter were $94.0 million, up 39.5% from $67.4 millio...

... VA,s Office of Research and Development is at th...eatments based on new knowledge about the role of ... to study genomics--the use of patients, individua...ed network of basic research and clinical applicat...

...ining the mechanism of a novel therapy that uses m... showed the treatment to be a promising alternativ...nial magnetic stimulation, or TMS. Study findings...ntrolled clinical study by Ohio State University M...

Physician and Author to Share Clinically Proven System for Permanent Weight Loss and Optimal Health in Westerville and Dublin, Ohio Areas New G1G Student Medical Insurance and Student Fee Protection Now on StuFund Web Site Women 10 times more likely to do breast self-exams correctly with intervention, KP study finds BioMed Realty Trust Reports First Quarter 2009 Operating and Financial Results Video: Turning Hope Into Reality - Genomics Research at the VA New therapy based on magnetic stimulation shows promise for non-drug treatment for migraine

(Date:12/3/2009)...TER, N.Y., Dec. 3 Virtua...er of quantitative imaging for clinical trials, an...ethod for 4D Reconstruction and Visualization" rec...pics, Vice President of Technology and Product Dev...ed that Japan has recognized the uniqueness of Vir...

(Date:12/3/2009)..., ROTTERDAM, The Netherlands, December 3 /PR...ny focused on the discovery and development of hum...y(TM) platform, today,announced the successful sec.... The Company raised an additional EUR 3.0 million...investors, Credit Agricole Private Equity and,VIB ...

(Date:12/2/2009)... NEW YORK, Dec. 2 Reportlinker.com...ailable in its catalogue: ,, Cardiac Pacemake...eportlinker.com/p0164335/Cardiac-Pacemakers---A-Wo...constitute a major segment in a rapidly expanding ...ac pacemakers market is characterized by relativel...

[0] VirtualScopics Receives Issuance in Japan of Prominent Patent [0] arGEN-X Concludes EUR 12.5 Million Series A Financing Round [0] Reportlinker Adds Cardiac Pacemakers - A World Market Analysis

...r Similar to Seven-Day in, Achieving Red Blood Cel...t in All MDS Patients Tested...Hematology (ASH) Meeting, ATLANTA, Dec. 11 Pharm...nterim data from a Phase 2 clinical trial,evaluati... Vidaza(R),(azacitidine for injection) that demons...

...city With Equivalent Complete Re...erapeutics, Inc.,(CTI) (Nasdaq and MTAX: CTIC) ann...II/III randomized study comparing CPOP-R to CHOP-R...essive non-Hodgkin,s lymphoma,(NHL) showed patient...(grade 3/4) toxicities including severe infection ...

Other Medicine Technology:MDS Patients on Five-Day Vidaza(R) Dosing Schedules Achieve Transfusion Independence Consistent with Seven-day Schedule 2 MDS Patients on Five-Day Vidaza(R) Dosing Schedules Achieve Transfusion Independence Consistent with Seven-day Schedule 3 MDS Patients on Five-Day Vidaza(R) Dosing Schedules Achieve Transfusion Independence Consistent with Seven-day Schedule 4 MDS Patients on Five-Day Vidaza(R) Dosing Schedules Achieve Transfusion Independence Consistent with Seven-day Schedule 5 MDS Patients on Five-Day Vidaza(R) Dosing Schedules Achieve Transfusion Independence Consistent with Seven-day Schedule 6 Pixantrone Versus Doxorubicin in CHOP-R Therapy for First-line Treatment of Aggressive Non-Hodgkin's Lymphoma Preliminary Results Presented at American Society of Hematology (ASH) Annual Meeting 2 Pixantrone Versus Doxorubicin in CHOP-R Therapy for First-line Treatment of Aggressive Non-Hodgkin's Lymphoma Preliminary Results Presented at American Society of Hematology (ASH) Annual Meeting 3 Pixantrone Versus Doxorubicin in CHOP-R Therapy for First-line Treatment of Aggressive Non-Hodgkin's Lymphoma Preliminary Results Presented at American Society of Hematology (ASH) Annual Meeting 4 Pixantrone Versus Doxorubicin in CHOP-R Therapy for First-line Treatment of Aggressive Non-Hodgkin's Lymphoma Preliminary Results Presented at American Society of Hematology (ASH) Annual Meeting 5

MDS Patients on Five-Day Vidaza(R) Dosing Schedules Achieve Transfusion Independence Consistent with Seven-day Schedule Pixantrone Versus Doxorubicin in CHOP-R Therapy for First-line Treatment of Aggressive Non-Hodgkin's Lymphoma Preliminary Results Presented at American Society of Hematology (ASH) Annual Meeting

Multi Dop T1

EZ-Dop

...owerful automated system capable of handling any c...m 6 user-programmable test protocols to begin a fu...tests not included in the comprehensive list of au...ler, PVR and PPG instrument modes. Provides high f...

CD Horizon M10

Medicine Products:

Multi Dop T1 EZ-Dop Imexlab 9100HS CD Horizon M10

Aegis Living Was Created To Place People First in Senior and Assisted Living C...(d. I thought 'Why do people think this ...),Health